NutriForward announced that the Food and Drug Administration (FDA) has cleared their patented product RiduZone tablets as a dietary supplement for regulation and support of healthy weight, appetite, body-fat composition, and cholesterol levels in adults.
RiduZone is a metabolite of oleic acid that provides more oleoylethanolamide (OEA) than what the body naturally produces. OEA is a metabolite made in the small intestines that regulates hunger by sending a signal to the brain and inducing satiety. RiduZone is released in the small intestine and binds to PPAR-α receptors which sends an alert to the brain via the peripheral nerve to induce satiety and increase body fat metabolism.
RiduZone taken 30 minutes before breakfast and dinner will make users feel full during meals to reduce the amount of food consumed.
RiduZone will be available in 60-count bottles in October 2015.
For more information call (844) RIDU-ZONE or visit RiduZone.com.